Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 7467-35-8 | MDL No. : | MFCD00464051 |
Formula : | C9H10N2O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | SQRSIOZFPSFABI-UHFFFAOYSA-N |
M.W : | 162.19 | Pubchem ID : | 344177 |
Synonyms : |
|
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P301+P312-P302+P352-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
72% | With sodium hydroxide In ethanol; water at 0 - 5℃; for 0.5h; | |
72% | With potassium hydroxide In ethanol; water at 0 - 20℃; for 1.25h; | 2.2.2. Synthesis of (1-methyl-1H-benzo[d]imidazol-2-yl)methanol (Hmbm) To 1.2 eq. (2.3 g, 0.041 mol) of KOH dissolved in a 50% (v/v) water-ethanol mixture (14 mL), 5.1 g (0.034 mol) of 1-(1H-benzimidazol-2-yl) methanol was added. The solution was cooled to 0 °C, and 5 mL of dimethyl sulfate was added dropwise over 30 min (the temperature of the mixture did not exceed 5 °C). The mixture was kept under stirring at 0 °C for 30 min and at room temperature for additional 15 min. The solid obtained was recovered by filtration and washed with water, giving the title compound as a white solid. It was purified by recrystallization from a mixture of CH3CN/EtOH. White solid; Yield: 4 g (72%); M.p. 122-124 °C; 1H NMR (250 MHz, CDCl3): δ 7.76-7.64 (m, 1H), 7.29-7.19 (m, 3H), 5.13 (OH, br s, 1H), 4.88 (CH2, s, 2H), 3.81 (N-CH3, s, 3H); FT-IR (4000-600 cm-1): 3450-2800, 1639, 1454, 1312, 1007, 860, 744, 567; UV-vis (MeOH) (λmax, nm (logε, M-1 cm-1): 280(5.35), 268(5.18), 244(5.14), 219(5.06). |
48% | With sodium hydroxide In methanol; water at 100℃; for 10h; | General procedure for the preparation of N-methyl-2-hydroxymethylbenzimidazole derivatives (6a-c) General procedure: A mixture of 2-hydroxymethybenzimidazole derivatives (5ac,0.023 mol), dimethyl sulfate (2.37 ml, 0.025 mol), NaOH (1g,0.025 mol in 3 ml water) in methanol (15 ml) was refluxed for 10 h at 100 oC. The mixture was diluted with water (15 ml) and extracted with chloroform (3x30 ml). The organic layer was washed with brine, dried over Na2SO4 and concentrated under reduced pressure. The precipitate formed was crystallized from water. |
With methanol; sodium hydroxide | ||
With sodium hydroxide |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | With dichlorosulfoxide In dichloromethane at 20℃; | 13 Example 13; 2-Chloromethyl-1-methyl-1H-benzoimidazole; (1-Methyl-1H-benzoimidazol-2-yl)-methanol (330 mg, 2.03 mmol) was dissolved in dichloromethane (15 mL), thionyl chloride (1.5 mL) was added drop wise. The reaction mixture was stirred at room temperature for overnight. The solvent was then removed from the reaction mixture by concentration in vacuo. The residue was dried on vacuum pump. Yellow solid was obtained as product (520 mg, yield: quantity).1HNMR (300 MHz, CDCl3): (ppm) 7.98 (br, 1H), 7.86 (br, 1H), 7.72 (m, 2H), 5.32 (s, 2H), 4.15 (s, 3H) |
94% | With dichlorosulfoxide In dichloromethane at 20℃; for 6h; | |
58.9% | With PS-triphenylphosphine resin In Carbon tetrachloride for 3h; Reflux; | 49 2-chloromethyl-l -methyl- lH-benzoimidazole (Compound 49b)A suspension of Compound 49a (255 mg, 1.57 mmol) and PS-triphenylphosphine resin (loading 2.2 mmol/g) in CC14 (15 ml) was refluxed for 3 hours. The resin was filtered and washed and then the organic solvent was evaporated off in vacuo. The crude was used in the following step without any further purification. Yield: 58.9 %.MS: [M+H]+ = 181.3 |
50% | With dichlorosulfoxide In dichloromethane for 5h; Reflux; | General procedure for the preparation of N-methyl-2-chloromethylbenzimidazole derivatives (7a-c) General procedure: The mixture of appropriate N-methyl-2-hydroxymethylbenzimidazole derivatives (6a-c, 0.01 mol), thionyl chloride(0.1 mol) in 30 ml dichloromethane were heated to reflux and stirred for 5 hours. The solvent was evaporated, and the residue was subsequently used without further purification. |
36% | In dichlorosulfoxide | 42 Example 42 A solution of 2-hydroxymethyl-1-methylbenzimidazole (1.1 g, 6.7 mmol) in thionyl chloride (10 ml) was stirred at ambient temperature for 15 minutes and then heated at reflux for 15 minutes. The volatiles were removed by evaporation and the residue purified by column chromatography eluding with methylene chloride/methanol (95/5) to give 2-chloromethyl-1-methylbenzimidazole (506 mg, 36%). 1 H NMR Spectrum: (DMSOd6; CF3 COOD) 4.07(s, 3H); 5.38(s, 2H); 7.6-7.7(m, 2H); 7.9(d, 1H); 8.05(dd, 1H) MS-ESI: 181 [MH]+ |
36% | Stage #1: (1-methyl-1H-benzimidazol-2-yl)methanol With dichlorosulfoxide at 20℃; for 0.25h; Stage #2: for 0.25h; Heating / reflux; | |
With dichlorosulfoxide | ||
255 mg | With dichlorosulfoxide In dichloromethane for 3h; | |
With dichlorosulfoxide |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
45% | With sulfuric acid; silver nitrate In methanol; water for 3h; Heating; | |
45% | With paraformaldehyde In methanol; dichloromethane | 42 Example 42 The starting material was prepared as follows: A solution of 1 -methylbenzimidazole (2.5 g, 19 mmol), (J. Chem. Soc. 1929, 2820-2828), and paraformaldehyde (2 g) was heated at 165° C. for 30 minutes. Further paraformaldehyde (1 g) was added and heating continued for 2 hours. The mixture was allowed to cool and was purified by column chromatography eluding with methylene chloride, followed by methylene chloride/methanol (95/5) to give 2-hydroxymethyl-1-methylbenzimidazole (1.34 g, 45%). 1 H NMR Spectrum: (DMSOd6) 3.84(s, 3H); 4.73(s, 2H); 5.57(br s, 1H); 7.19(t, 1H); 7.25(t, 1H); 7.54(d, 1H); 7.60(d, 1H) MS - ESI: 185 [MNa]+ |
In formaldehyd; dichloromethane | 81.a a a (1-Methyl-1H-benzimidazol-2-yl)methanol 1-Methylbenzimidazole (5.0 g, 0.038 mol) was stirred at reflux in 37 wt % aqueous formaldehyde (50 ml) for 24 h. The solution was allowed to cool to room temperature then basified with saturated sodium hydrogen carbonate solution and then extracted with. dichloromethane (3*50 ml). The combined organic layers were dried over magnesium sulfate and were concentrated in vacuo. The residue was purified by flash chromatography on silica gel, eluding with 2.5 to 10% methanol in dichloromethane. The resultant semi-solid was triturated with isohexane to yield a solid, which was then recrystallized from ethyl acetate/isohexane, yielding (1-methyl-1H-benzimidazol-2-yl)methanol as a white solid (0.71 g). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
96% | With hydrogenchloride In water at 130℃; Sealed tube; | |
76% | With phosphoric acid at 130℃; for 3h; | Synthesis of (1H-benzoimidazol-2-yl)methyl 1H-indole-3-carboxylate derivatives (5a-c) As shown in Scheme 1, to a mixture of 1 (10 mmol) and glycolic acid (2.28 g, 30mmol) was added concentrated H3PO4 (20 mL). The reaction was refluxed at 130°C for 3 h before being quenched with 20% NaOH. 2-Hydroxymethyl-3-methyl-benzimidazole (2) was collected by filtration.20,21 To produce indole-3-carboxylic acid derivatives 4a-c, compounds 3a-c (20 mmol) were dissolved in dimethylformamide (DMF, 10 mL) and trifluoroacetic anhydride (4.2 mL, 30mmol) was added dropwise at 0°C. After stirring for 3.5 h at room temperature (rt), water was added and the mixture was filtered. The collected solid was treated with 20% NaOH (40mL, 0.2mol) at 55°C for 6h. After cooling to rt, the solution was extracted with Et2O. The aqueous phase was acidified with concentrated HCl and the product was filtered.22-24 Finally, compounds 4a-c (5mmol) were dissolved in THF (25mL), then 1,3-dicyclohexylcarbodiimide (DCC) (1.24g, 6mmol) and 4-dimethylaminopyridin (DMAP; 0.12g, 1mmol) were slowly added. After stirring for 30min at rt, compound 2 (5mmol) was added and the mixture was stirred for 7-9h at rt. The by-product N,N′-dicyclohexylurea, was removed by filtration. The filtrate was concentrated in vacuo to give a solid. The solid was dissolved in CH2Cl2 and recrystallization. After filtration, the product was obtained. |
With hydrogenchloride Heating; |
Stage #1: glycolic Acid; N-methyl-1,2-phenylenediamine With hydrogenchloride In water at 95℃; for 12h; Inert atmosphere; Stage #2: With sodium hydrogencarbonate In water Saturated solution; | ||
With hydrogenchloride In water at 65 - 100℃; for 5h; | 3.2.1. Synthesis and Purification of Compound 2a-2d General procedure: The procedures were conducted according to the literature [16]. Glycolic acid (15.24 g, 0.2 mol)was dissolved in 40 mL HCl (20% aqueous) in the flask. When the temperature reached 65 C,compound 1a-1d (16.27 g, 0.15 mol) was added at three times, then refluxed at 100 C for 5 h. After cooling to room temperature, the solution was basified with NaOH (15%, aqueous) until itreached pH 9.0 to precipitate the desired compounds 2a-2d (in 75%-85% yield). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
92% | With tetrabutylammomium bromide; potassium hydroxide In tetrahydrofuran at 0℃; | |
86% | With sodium hydroxide In acetone for 1h; | |
43.4% | for 24h; |
With tetrabutylammomium bromide; potassium hydroxide In tetrahydrofuran at 0℃; | ||
With potassium carbonate In N,N-dimethyl-formamide | ||
With potassium carbonate In N,N-dimethyl-formamide at 20℃; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
62% | With water; sodium hydrogencarbonate; sodium sulfite for 5h; Heating; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
99% | With diisobutylaluminium hydride In tetrahydrofuran at 0℃; for 1.5h; | |
88% | With diisobutylaluminium hydride In tetrahydrofuran; hexane at 0℃; for 1h; | |
50.4% | Stage #1: 1-Methyl-1H-benzoimidazole-2-carbaldehyde With sodium tetrahydridoborate In tetrahydrofuran at 20℃; for 24h; Stage #2: With water monomer In tetrahydrofuran | 49 2- hydroxymethyl-l -methyl-1 H-benzimidazole (Compound 49a)A suspension of l -methyl-2-formyl-l H-benzimidazole (500 mg, 3.12 mmol) and NaBH4 (134 mg, 3.43 mmol) in anhydrous THF (25 ml) was stirred for 24 hours at r.t.. The reaction mixture was quenched with water, extracted with EtOAc, dried over Na2S04 and evaporated to dryness in vacuo. The crude was purified by automated flash chromatography (HorizonTM - Biotage) eluting with CHC13 - 1.7M NH3 sol. in MeOH 100:2 giving the title product as white solid. Yield: 50.4 %. MS: [ +H]+ = 163.5 |
Stage #1: 1-Methyl-1H-benzoimidazole-2-carbaldehyde With lithium naphthalenide In tetrahydrofuran at 0℃; Stage #2: With water monomer In tetrahydrofuran | ||
Stage #1: 1-Methyl-1H-benzoimidazole-2-carbaldehyde With sodium tetrahydridoborate; ethanol at 20℃; Stage #2: With water monomer In ethyl acetate | 12 Example 12; (1-Methyl-1H-benzoimidazol-2-yl)-methanol; Sodium borohydride (472 mg, 12.48 mmol) was added to the solution of 1-methyl-1H-benzoimidazole-2-carbaldehyde (1 g, 6.24 mmol) in ethanol (50 mL). The reaction mixture was stirred at room temperature for overnight. The reaction mixture was condensed, the residue was diluted with ethyl acetate; water was added. The organic layer was washed with water and brine, dried over anhydrous sodium sulfate, filtered and condensed to give off-white solid as product (953 mg, 94%). This product was used in the later steps without further purification.1HNMR (300 MHz, CDCl3): (ppm) 7.63 (m, 1H), 7.21 (m, 3H), 4.84 (s, 2H), 3.75 (s, 3H) | |
With methanol; sodium tetrahydridoborate at 0 - 20℃; for 5h; | 47 To a 0°C solution of 1 -methyl- lH-benzimidazole-2-carbaldehyde (1.1 g, 6.8 mmol) in anhydrous methanol (50 mL) was added sodium borohydride (350 mg, 9.3 mmol). The reaction mixture was stirred at room temperature for 5 hours. Saturated ammonium chloride solution (20 mL) was added. Methanol was evaporated. The resultant mixture was extracted with EtOAc (3 x 50 mL) and CH2Cl2 (1 x 50 mL). The organic extracts were combined, dried over MgSO4, filtered, evaporated, and dried in vacuo. (1 -methyl- lH-benzimidazol-2-yl)methanol was obtained (1.1 g, 99% yield). The product was used without further purification. | |
With sodium tetrahydridoborate In tetrahydrofuran at 20℃; for 1h; Inert atmosphere; | (1-methyl-1H-benzo[d]imidazol-2-yl)methanol (5-5b). To a solution of 1-methyl- 1H-benzo[d]imidazole-2-carbaldehyde (5-5a, 150 mg, 936.49 umol, 1 eq) in THF (3 mL) was added NaBH4 (38.97 mg, 1.03 mmol, 1.1 eq) at 20°C under N2. The mixture was stirred at 20°C for 1 hour. LCMS showed 5-5a was comsumed completely and desired mass was detected. The reaction mixture was quenched by addition water (30 mL) at 20°C. The aqueous phase was extracted with ethyl acetate (25 mL*2). The combined organic phase was washed with brine (20 mL), dried with anhydrous Na2SO4, filtered and concentrated in vacuo. The residue was purified by prep-TLC (ethyl acetate: methanol = 20:1) to give 5-5b as a white solid.1H NMR (400MHz, CDCl3-d) 7.77-7.67 (m, 1H), 7.34-7.28 (m, 2H), 7.27- 7.23 (m, 1H), 4.91 (s, 2H), 3.83 (s, 3H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
76% | With sodium hydroxide In methanol at 20℃; for 0.5h; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 4 steps 1: 2 h / 125 - 130 °C 2: water / Heating 3: 75 percent / TEBAC; K2CO3 / acetonitrile / 20 °C 4: 76 percent / aq. NaOH / methanol / 0.5 h / 20 °C | ||
Multi-step reaction with 3 steps 1: 91 percent / triethylbenzylammonium hydroxide / dimethylformamide / 5 h / Heating 2: 74 percent / ethanol / 3 h / Heating 3: 62 percent / NaHCO3, Na2SO3, H2O / 5 h / Heating |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
96% | With di-tert-butyl-diazodicarboxylate; triphenylphosphine In 1,4-dioxane at 60℃; for 18h; Inert atmosphere; | |
96% | With di-tert-butyl-diazodicarboxylate; triphenylphosphine In 1,4-dioxane at 60℃; | 5 EXAMPLE 5 1-Methyl-2-[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-1-H-benzoimidazole To a solution of 4-(1-Methyl-4-pyridin-yl-pyrazol-3-yl)-phenol (50 mg) in dioxane (1 ml) was added triphenyl phosphine (83 mg), (1-Methyl-1-H-benzoimidazol-2-yl)-methanol (48 mg) and Di-t-butyl azodicarboxylate (73 mg). The reaction mixture was heated at 60° C. for 18, poured into 1 N NaOH, extracted 3* with chloroform, dried magnesium sulfate, filtered and concentrated. Purification via biotage MPLC eluding with 80% ethyl acetate/hexane provided the title compound (75 mg, 96%)). 1H NMR (400 MHz, CCDl3) δ 8.44 (d, J=6.2 Hz, 2 H), 7.76 (dd, J=7.1, 1.7 Hz, 1 H), 7.55 (s, 1H), 7.37-7.28 (m, 5 H), 7.15 (dd, J=4.6, 1.7 Hz, 2H), 7.05 (d, J=9.1 Hz, 2H), 5.38 (s, 2H), 3.94 (s, 3H) 3.88 (s, 3H); MS: (M+H m/z=396.2); PDE10 IC50=0.56 nm. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
83% | With Dess-Martin periodane In dichloromethane at 4℃; for 1h; | |
79% | With selenium(IV) oxide In toluene at 80 - 90℃; for 2h; | |
67% | With Dess-Martin periodane In dichloromethane at 0℃; for 6h; |
33% | With Dess-Martin periodane In dichloromethane at 0 - 20℃; | |
30% | With Dess-Martin periodane In dichloromethane at 4℃; for 1h; | Procedures for the synthesis of 2-carbonylbenzimidazoles 1-2. General procedure: Dess-Martin reagent (1.1 mmol) was added to a solution of benzimidazol-2-ylmethanol 4 or 7(1 mmol) in methylene chloride (10 mL). The reaction mixture was stirred at 4 °C for 1 h prior tobeing quenched with saturated aqueous sodium thiosulfate solution (3 mL). The subsequent mixturewas extracted with methylene chloride (3 × 10 mL). The combined organic extracts were dried overanhydrous magnesium sulfate and concentrated in vacuo to provide a crude product, which wascrystallized from methanol to give corresponding product.1-Methyl-1H-benzimidazole-2-carboxaldehyde (1) [3] was obtained as beige solid in 30%yield. M.p. 134-136°C from methanol. 1H NMR (500 MHz, CDCl3) δ 4.12 (s, NMe), 7.35-7.39 (m,1Harom.), 7.43-7.48 (m, 2Harom.), 7.90 (d, 1Harom., J = 10.3 Hz), 10.09 (s, 1H, CHO). 13C NMR (125MHz, CDCl3) δ 31.2, 110.5, 122.3, 124.0, 126.8, 136.9, 142.7, 146.1, 185.0. |
With manganese(IV) oxide In dichloromethane at 20℃; for 72h; | ||
With Dess-Martin periodane In dichloromethane at 0℃; for 6h; | ||
With Dess-Martin periodane In dichloromethane at 0 - 20℃; | ||
With manganese(IV) oxide In ethyl acetate at 65℃; for 1h; | 3.2.2. Synthesis and Purification of Compound 3a-3d General procedure: A solution of 2a-2d (2 mmol), MnO2 (3.48 g, 40 mmol) was added to EtOAc (120 mL), then refluxedat 65 C for 1 h (monitored by TLC). Afterwards the solution was filtered, and concentrated in vacuoto give pure compounds 3a-3d (in 60%-76% yield) [17]. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With phosphorus tribromide In dichloromethane at 20℃; | 47 To a solution of (1 -methyl- lH-benzimidazol-2-yl)methanol (1.1 g, 6.8 mmol) in anhydrous dichloromethane (60 mL) was added dropwise phosphorus tribromide (1.3 mL, 14.0 mmol). The mixture was stirred at room temperature overnight. Dichloromethane was evaporated. The residue was dried in vacuo, affording 2- (bromomethyl)-l -methyl- lH-benzimidazole hydrobromide. The product was used without further purification. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: hydrogenchloride / water / 6 h / Reflux 2: tetrabutylammomium bromide; potassium hydroxide / tetrahydrofuran / 0 °C | ||
Multi-step reaction with 2 steps 1: hydrogenchloride / water / 6 h / Reflux 2: tetrabutylammomium bromide; potassium hydroxide / tetrahydrofuran / 0 °C | ||
Multi-step reaction with 2 steps 1: hydrogenchloride / water / 6 h / 100 °C 2: potassium carbonate / N,N-dimethyl-formamide / 24 h / 20 °C |
Multi-step reaction with 2 steps 1: hydrogenchloride / water / 3 h / Reflux 2: 24 h | ||
Multi-step reaction with 2 steps 1: hydrogenchloride / water / Reflux 2: potassium carbonate / N,N-dimethyl-formamide | ||
Multi-step reaction with 2 steps 1: hydrogenchloride / water / Reflux 2: sodium hydroxide / water; methanol / 10 h / 100 °C | ||
Multi-step reaction with 2 steps 1: hydrogenchloride / water / Reflux 2: potassium carbonate / N,N-dimethyl-formamide / 20 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
30% | Stage #1: (1-methyl-1H-benzimidazol-2-yl)methanol With sodium hydride In N,N-dimethyl-formamide at 0 - 30℃; for 0.5h; Stage #2: 4-fluorobenzaldehyde In N,N-dimethyl-formamide at 0 - 30℃; for 24.25h; | |
30% | With sodium hydride In N,N-dimethyl-formamide at 0 - 30℃; for 24.5h; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With sodium hydride In N,N-dimethyl-formamide at 20℃; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
22.6% | With triphenylphosphine; diethylazodicarboxylate In tetrahydrofuran at 0 - 20℃; for 17h; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
20% | With triphenylphosphine; diethylazodicarboxylate In tetrahydrofuran at 0 - 20℃; for 17h; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
18% | With triphenylphosphine; diethylazodicarboxylate In tetrahydrofuran at 0 - 20℃; for 17h; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
20% | With triphenylphosphine; diethylazodicarboxylate In tetrahydrofuran at 0 - 20℃; for 17h; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
65% | With silver(l) oxide In 1,4-dioxane at 20℃; for 24h; | General Procedure: Isopropyl Picolinate (2)[5] General procedure: Freshly prepared Ag2O (2.20 mmol) was added at room temperature to a solution of pyridin-2-ylmethanol (1.00 mmol) and 2-iodopropane (2.20 mmol) in 1,4-dioxane (10 mL) and stirred for 24 h. The reaction mixture was filtered through a Celite bed and washed with ethyl acetate. Filtrate was concentrated under vacuum.The resulting material was purified by flash chromatography on a Biotage instrumentusing 4-g flash cartridge and eluted with 12-15% ethyl acetate in hexane to give isopropyl picolinate (2) (65% yield). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With potassium iodide; silver(l) oxide In dichloromethane at -20 - 20℃; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
52% | With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 24h; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
35% | With triethylamine In acetonitrile at 20℃; for 336h; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
49% | With di-tert-butyl (E)-azodicarboxylate; triphenylphosphine In tetrahydrofuran; toluene at 20℃; | 15 5.15. 1-(Cyclopropylmethyl)-5-[(1-methyl-1H-benzimidazol-2-yl)methoxy]-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin-4(1H)-one(16a) To a solution of 15 (100 mg, 0.32 mmol), 2-(1-methyl-1H-benzo[d]imidazol-2-yl)methanol (79 mg, 0.49 mmol) and triphenylphosphine(149 mg, 0.57 mmol) in THF (10 mL) was added (E)-di-tertbutyldiazene-1,2-dicarboxylate (20% toluene solution, 0.64 mL,0.49 mmol) at rt. After stirring at room temperature overnight,the mixture was concentrated under reduced pressure. The residuewas purified by silica gel column chromatography with EtOAc/hexaneand recrystallized from EtOAc to give 16a (72 mg, 49%) as awhite solid. 1H NMR (CDCl3) d 0.12-0.21 (2H, m), 0.40-0.50 (2H,m), 0.74-0.91 (1H, m), 3.53 (2H, d, J = 7.2 Hz), 3.97 (3H, s), 5.55(2H, s), 7.18 (1H, d, J = 2.3 Hz), 7.27-7.43 (8H, m), 7.71-7.79 (2H,m), 8.17 (1H, s). LC-MS (ESI) m/z 453.1 (M+H)+. Anal. Calcd forC26H24N6O2 + 0.2H2O: C, 68.47; H, 5.39; N, 18.43. Found: C, 68.51;H, 5.35; N, 18.59. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: manganese(IV) oxide / ethyl acetate / 1 h / 65 °C 2: methanol / 2 h / 20 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: manganese(IV) oxide / ethyl acetate / 1 h / 65 °C 2: methanol / 2 h / 20 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: manganese(IV) oxide / ethyl acetate / 1 h / 65 °C 2: methanol / 2 h / 20 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: manganese(IV) oxide / ethyl acetate / 1 h / 65 °C 2: methanol / 2 h / 20 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: manganese(IV) oxide / ethyl acetate / 1 h / 65 °C 2: methanol / 2 h / 20 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: manganese(IV) oxide / ethyl acetate / 1 h / 65 °C 2: methanol / 2 h / 20 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: manganese(IV) oxide / ethyl acetate / 1 h / 65 °C 2: methanol / 2 h / 20 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: manganese(IV) oxide / ethyl acetate / 1 h / 65 °C 2: methanol / 2 h / 20 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
66.8% | With triethylamine at 140℃; for 48h; Autoclave; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
63.4% | With triethylamine at 140℃; for 48h; Autoclave; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
44% | In 1,2-dimethoxyethane at 20℃; for 72h; | General procedure General procedure: To a stirred solution of 1 equiv of Hmbm dissolved in anhydrous DME (0.15 M) (e.g. 0.2 g in 10 mL), 0.5 equiv of the appropriate metal salt was added. The solution was stirred at room temperature for 72 h for 1 and 48 h for 2. The resulting solid was recovered by filtration and washed with cold DME (3 × 5 mL) and then dried in air. Suitable crystals for X-ray diffraction were collected by slow evaporation at rt from a concentrated CH3CN solution. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
52% | In 1,2-dimethoxyethane at 20℃; for 72h; | General procedure General procedure: To a stirred solution of 1 equiv of Hmbm dissolved in anhydrous DME (0.15 M) (e.g. 0.2 g in 10 mL), 0.5 equiv of the appropriate metal salt was added. The solution was stirred at room temperature for 72 h for 1 and 48 h for 2. The resulting solid was recovered by filtration and washed with cold DME (3 × 5 mL) and then dried in air. Suitable crystals for X-ray diffraction were collected by slow evaporation at rt from a concentrated CH3CN solution. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
36% | With lithium hexamethyldisilazane In tetrahydrofuran at 0℃; for 0.25h; | 107 Examples 104-106 General procedure: Following the procedure of Example 1, using the appropriate starting materials (X is a leaving group such as halo, methylsulfonyl, arylsulfonyl), but often by adding sodium hydride to an ice-cooled mixture of Ar-X and RCH2OH in DMF instead of adding sodium alkoxide to asolution of the alcohol before then adding Ar-X, and usually with chromatography on silica for purification instead of recrystallisation, there were thus obtained the following Examples (Ex.104-106): |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
41% | With lithium hexamethyldisilazane In tetrahydrofuran at 0℃; for 0.25h; | 105 Examples 104-106 General procedure: Following the procedure of Example 1, using the appropriate starting materials (X is a leaving group such as halo, methylsulfonyl, arylsulfonyl), but often by adding sodium hydride to an ice-cooled mixture of Ar-X and RCH2OH in DMF instead of adding sodium alkoxide to asolution of the alcohol before then adding Ar-X, and usually with chromatography on silica for purification instead of recrystallisation, there were thus obtained the following Examples (Ex.104-106): |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
81% | With trifluorormethanesulfonic acid at 140℃; for 2.5h; | General procedures for the reaction of benzimidazoles 3-8 with arenes in TfOH in highpressure tube. Synthesis of compounds 12-14 (Tables 4, 5, Scheme 3). General procedure: Solution ofbenzimidazole (0.1 mmol) in TfOH (1 mL) and arene (0.1 mL) was magnetically stirred at 140 °Cin glass high pressure tube for 2.5 h, then poured into water (50 mL). After extraction with CH2Cl2(3 × 30 mL), the combined extracts were consequently washed with water (50 mL), saturatedaqueous solution of Na2CO3 (30 mL), water (50 mL), dried with anhydrous Na2SO4 and evaporatedin vacuo to give crude products, which were subjected to chromatographic separation on silica gelusing petroleum ether/diethyl ether as an eluent. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
35% | In methanol at 100℃; for 48h; Autoclave; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
75% | Stage #1: (1-methyl-1H-benzimidazol-2-yl)methanol; zinc(II) nitrate hexahydrate; sodium acetate In acetonitrile for 0.0333333h; Stage #2: With triethylamine In acetonitrile at 80℃; for 48h; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With lithium aluminium tetrahydride In tetrahydrofuran at 0 - 20℃; for 1h; Inert atmosphere; | 314.3 [00600] Step 3: (1 -methyl- 1 //-benzol c/|imidazol-2-yl)methanol [00601] To a stirring solution of ethyl 1 -methyl- 1 //-benzol i/|imidazole-2-carboxylate (150 mg, 0.74 mmol) in THF (4 mL) at 0 °C was added L1AIH4 (1 M, 2.2lmL, 2.21 mmol) under nitrogen. After stirring at room temperature for 1 h, the reaction mixture was quenched by 4 drops of water. The mixture was filtered, and concentrated to get crude (1 -methyl- 1H- benzo| <7|imidazol-2-yl Jmethanol (125 mg, 104%) as yellow oil. ES-MS (m/z): [M+l]+ = 163.2. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
60% | Stage #1: 5-bromo-1H-indole-3-carboxylic acid With dmap; dicyclohexyl-carbodiimide In tetrahydrofuran at 20℃; for 0.5h; Stage #2: (1-methyl-1H-benzimidazol-2-yl)methanol In tetrahydrofuran at 20℃; | Synthesis of (1H-benzoimidazol-2-yl)methyl 1H-indole-3-carboxylate derivatives (5a-c) General procedure: As shown in Scheme 1, to a mixture of 1 (10 mmol) and glycolic acid (2.28 g, 30mmol) was added concentrated H3PO4 (20 mL). The reaction was refluxed at 130°C for 3 h before being quenched with 20% NaOH. 2-Hydroxymethyl-3-methyl-benzimidazole (2) was collected by filtration.20,21 To produce indole-3-carboxylic acid derivatives 4a-c, compounds 3a-c (20 mmol) were dissolved in dimethylformamide (DMF, 10 mL) and trifluoroacetic anhydride (4.2 mL, 30mmol) was added dropwise at 0°C. After stirring for 3.5 h at room temperature (rt), water was added and the mixture was filtered. The collected solid was treated with 20% NaOH (40mL, 0.2mol) at 55°C for 6h. After cooling to rt, the solution was extracted with Et2O. The aqueous phase was acidified with concentrated HCl and the product was filtered.22-24 Finally, compounds 4a-c (5mmol) were dissolved in THF (25mL), then 1,3-dicyclohexylcarbodiimide (DCC) (1.24g, 6mmol) and 4-dimethylaminopyridin (DMAP; 0.12g, 1mmol) were slowly added. After stirring for 30min at rt, compound 2 (5mmol) was added and the mixture was stirred for 7-9h at rt. The by-product N,N′-dicyclohexylurea, was removed by filtration. The filtrate was concentrated in vacuo to give a solid. The solid was dissolved in CH2Cl2 and recrystallization. After filtration, the product was obtained. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
47% | Stage #1: 1H-indole-3-carboxylic acid With dmap; dicyclohexyl-carbodiimide In tetrahydrofuran at 20℃; for 0.5h; Stage #2: (1-methyl-1H-benzimidazol-2-yl)methanol In tetrahydrofuran at 20℃; | Synthesis of (1H-benzoimidazol-2-yl)methyl 1H-indole-3-carboxylate derivatives (5a-c) General procedure: As shown in Scheme 1, to a mixture of 1 (10 mmol) and glycolic acid (2.28 g, 30mmol) was added concentrated H3PO4 (20 mL). The reaction was refluxed at 130°C for 3 h before being quenched with 20% NaOH. 2-Hydroxymethyl-3-methyl-benzimidazole (2) was collected by filtration.20,21 To produce indole-3-carboxylic acid derivatives 4a-c, compounds 3a-c (20 mmol) were dissolved in dimethylformamide (DMF, 10 mL) and trifluoroacetic anhydride (4.2 mL, 30mmol) was added dropwise at 0°C. After stirring for 3.5 h at room temperature (rt), water was added and the mixture was filtered. The collected solid was treated with 20% NaOH (40mL, 0.2mol) at 55°C for 6h. After cooling to rt, the solution was extracted with Et2O. The aqueous phase was acidified with concentrated HCl and the product was filtered.22-24 Finally, compounds 4a-c (5mmol) were dissolved in THF (25mL), then 1,3-dicyclohexylcarbodiimide (DCC) (1.24g, 6mmol) and 4-dimethylaminopyridin (DMAP; 0.12g, 1mmol) were slowly added. After stirring for 30min at rt, compound 2 (5mmol) was added and the mixture was stirred for 7-9h at rt. The by-product N,N′-dicyclohexylurea, was removed by filtration. The filtrate was concentrated in vacuo to give a solid. The solid was dissolved in CH2Cl2 and recrystallization. After filtration, the product was obtained. 1-Methyl-1H-benzo(d) 1H-indole-3-carboxylate (5a). White solid; 47% yield; m.p. 207-209°C. 1H NMR (500 MHz, DMSO-d6): δ 3.65 (s, 3H, CH3), 5.42 (s, 2H, CH2), 7.02 (t, J =7.5 Hz, 1H, ArH), 7.11 (t, J= 7.5Hz, 1H, ArH), 7.18 (t, J =7.5Hz, 1H, ArH), 7.24 (t, J= 7.5 Hz, 1H, ArH), 7.35 (s, 1H, CH-N), 7.51 (d, J =8.0Hz, 1H, ArH), 7.55 (d, J = 8.0Hz, 1H, ArH), 7.60 (d, J= 8.0Hz, 2H, ArH). 11.86 (s, 1H, NH). 13C NMR (126MHz, DMSO-d6): δ 163.08, 148.96, 136.42, 134.21, 132.92, 131.51, 125.85, 125.69, 125.58, 122.64, 121.64, 120.18, 115.03, 112.64, 112.56, 104.46, 55.37, 31.38. FTIR: 3447, 3087, 2920, 1690, 1537, 1441, 1365, 1340, 1244, 1174, 778, and 748 cm-1. HRMS (EI): m/z [M]+calcd for C18H15N3O2: 305.1164; found: 305.1261. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
65% | Stage #1: 5-Methoxyindole-3-carboxylic acid With dmap; dicyclohexyl-carbodiimide In tetrahydrofuran at 20℃; for 0.5h; Stage #2: (1-methyl-1H-benzimidazol-2-yl)methanol In tetrahydrofuran at 20℃; | Synthesis of (1H-benzoimidazol-2-yl)methyl 1H-indole-3-carboxylate derivatives (5a-c) General procedure: As shown in Scheme 1, to a mixture of 1 (10 mmol) and glycolic acid (2.28 g, 30mmol) was added concentrated H3PO4 (20 mL). The reaction was refluxed at 130°C for 3 h before being quenched with 20% NaOH. 2-Hydroxymethyl-3-methyl-benzimidazole (2) was collected by filtration.20,21 To produce indole-3-carboxylic acid derivatives 4a-c, compounds 3a-c (20 mmol) were dissolved in dimethylformamide (DMF, 10 mL) and trifluoroacetic anhydride (4.2 mL, 30mmol) was added dropwise at 0°C. After stirring for 3.5 h at room temperature (rt), water was added and the mixture was filtered. The collected solid was treated with 20% NaOH (40mL, 0.2mol) at 55°C for 6h. After cooling to rt, the solution was extracted with Et2O. The aqueous phase was acidified with concentrated HCl and the product was filtered.22-24 Finally, compounds 4a-c (5mmol) were dissolved in THF (25mL), then 1,3-dicyclohexylcarbodiimide (DCC) (1.24g, 6mmol) and 4-dimethylaminopyridin (DMAP; 0.12g, 1mmol) were slowly added. After stirring for 30min at rt, compound 2 (5mmol) was added and the mixture was stirred for 7-9h at rt. The by-product N,N′-dicyclohexylurea, was removed by filtration. The filtrate was concentrated in vacuo to give a solid. The solid was dissolved in CH2Cl2 and recrystallization. After filtration, the product was obtained. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With triethylamine In acetonitrile at 80℃; for 48h; Sealed tube; | Weigh 0.0160 g of (1-methyl-1H-benzimidazol-2-yl) methanol (HL) and 0.0100 g of Cu(ClO4)2·6H2O and mix them in 8 mL of acetonitrile solvent; Transfer the above solution into a 15 mL reactor with a polytetrafluoroethylene liner, then add 0.23 mL of triethylamine to the solution and seal the reactor.After reacting in a constant temperature oven at a temperature of 80°C for 48 hours, the temperature is lowered to room temperature at 5°C per hour, and filtered to obtain blue-violet crystals. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
45% | In acetonitrile at 60℃; for 48h; | Complex 1 Weighed 1 mmol HL (162 mg) and 0.5 mmol Cu(ClO4)26H2O (185 mg) in 15 mL Teflon reactor, and added 10 mL CH3CN. Stired for 10 min to dissolve. Finally, reacted at 60 °C for two days. The bluish violet crystals were obtained. Yield 45% (Based on HL) .IR data for 1 (KBr, cm -1): 3779 (w), 3045 (m), 2881 (m), 2810 (m), 2648 (m), 1495 (s), 1453 (s), 1326 (m), 1094 (s), 946 (w), 752 (s), 617 (w), 453 (w). Elemental analyses calc. (%) for [C36H38ClCu2N8O8]: C 49.51, H 4.39, N 12.83. Found: C 49.33, H 4.45, N 12.76. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: dichlorosulfoxide / dichloromethane / 6 h / 20 °C 2: 1,4-dioxane / 100 °C / Sealed tube |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 3 steps 1: dichlorosulfoxide / dichloromethane / 6 h / 20 °C 2: 1,4-dioxane / 100 °C / Sealed tube 3: acetonitrile / 3 h / 20 °C / Inert atmosphere |
Tags: 7467-35-8 synthesis path| 7467-35-8 SDS| 7467-35-8 COA| 7467-35-8 purity| 7467-35-8 application| 7467-35-8 NMR| 7467-35-8 COA| 7467-35-8 structure
[ 330472-50-9 ]
(5-Amino-1-methyl-1H-benzoimidazol-2-yl)-methanol
Similarity: 0.92
[ 155221-51-5 ]
(1,6-Dimethyl-1H-benzo[d]imidazol-2-yl)methanol
Similarity: 0.92
[ 68426-72-2 ]
(1,5-Dimethyl-1H-benzo[d]imidazol-2-yl)methanol
Similarity: 0.92
[ 1158781-00-0 ]
(5-Amino-1-methyl-1H-benzoimidazol-2-yl)methanol dihydrochloride
Similarity: 0.91
[ 21269-78-3 ]
(1-Ethyl-1H-benzo[d]imidazol-2-yl)methanol
Similarity: 0.89
[ 5538-35-2 ]
O-((1-Methyl-1H-benzo[d]imidazol-2-yl)methyl)hydroxylamine
Similarity: 0.94
[ 330472-50-9 ]
(5-Amino-1-methyl-1H-benzoimidazol-2-yl)-methanol
Similarity: 0.92
[ 155221-51-5 ]
(1,6-Dimethyl-1H-benzo[d]imidazol-2-yl)methanol
Similarity: 0.92
[ 27243-70-5 ]
2-(Ethoxymethyl)-1-methyl-1H-benzo[d]imidazole
Similarity: 0.92
[ 68426-72-2 ]
(1,5-Dimethyl-1H-benzo[d]imidazol-2-yl)methanol
Similarity: 0.92
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :